Prognostic Analysis of Different Treatment Options for Cerebral Hemorrhage

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorThe Affiliated Hospital Of Guizhou Medical University

About this trial

To analyze the influence of early hematoma morphology on hematoma expansion, optimize the treatment plan for cerebral hemorrhage, and guide the treatment of patients with cerebral hemorrhage in combination with clinical practice.

Eligibility criteria

Qualifiers

Age 18-80 years old;

Intracerebral hemorrhage was diagnosed by head CT examination;

Disqualifiers

Multiple intracranial hemorrhage;

Intracranial hemorrhage caused by intracranial tumor, aneurysm, trauma, infarction or other lesions;

Coagulation disorders or a history of taking anticoagulants;

Infectious meningitis, systemic infection;

Trial design

Treatments tested in this trial

  • Stereotactic intracranial hematoma puncture
  • decompressive craniectomy
  • Neuroendoscopic

Treatment groups

1,000 Participants
are divided into 4 treatment groups